Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106117221A details a novel Ni-porphyrin-triphenylene synthesis. Offers high stability and scalable routes for organic photovoltaic and OLED manufacturing supply chains.
Novel pentavalent phosphine ligand system enhances aldehyde production efficiency and stability for pharmaceutical and fine chemical manufacturing supply chains.
Patent CN110339861A reveals solid acid catalysis for MDA. Enhances purity and supply chain reliability for polyurethane precursor manufacturing.
Patent CN113755462B reveals high-activity enzyme mutants for chiral beta-amino acid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1635128A enables high-purity GABA production via enzymatic conversion. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Zr-HPAA catalyst enables high-purity geraniol production with simplified supply chain and cost efficiency for global fragrance manufacturers.
Novel patent CN103012074A details high-yield aromatic methyl ether synthesis using recycled monochloromethane, offering cost reduction in pharma intermediates manufacturing.
Patent CN105130769A reveals a high-yield Pd-Ferrocene catalytic method for alkynone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101486687B details a low-toxicity synthesis of Setastine Hydrochloride using Xylene and PEG400, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel solid superacid catalyzed synthesis ensures high purity and reduced waste for reliable supply chain integration and cost effective manufacturing processes.
Patent CN115466288B reveals a room-temperature method for chiral diphosphine selenium ligands, offering high yield and simplified supply chains for asymmetric catalysis manufacturing.
Patent CN108033899B reveals a safe, ambient-temperature route for Atorvastatin intermediates. Discover cost reduction and supply chain advantages.
Patent CN105439856A reveals high-yield dilauryl carbonate production. Oxometallate ionic liquid catalyst ensures supply chain stability and cost efficiency.
Patent CN117247928A details mutant acylase for 7-ACA. Offers greener, efficient production for reliable pharmaceutical intermediates supplier partners.
Novel Ru-Zr catalytic method for diaryl phosphate esters. High purity pharmaceutical intermediates with reduced costs and scalable supply chain solutions for global buyers.
Patent CN104531630B enables high-enantioselectivity enzyme mutants. Achieve substantial cost reduction in pharma intermediates manufacturing with scalable biocatalysis.
Patent CN110305122B reveals advanced C4-functionalized Pybox ligands offering superior enantioselectivity and streamlined synthesis for pharmaceutical intermediate manufacturing.
Patent CN102329332B reveals stable organo-aluminum catalysts for high-selectivity citronellal cyclization. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN105061290B reveals a novel Ce/Ag catalytic route for fluorinated indolinones. Achieve high yields and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN105969836A details a lipase YCJ01 catalyzed process for high-purity vinelactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.